Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 11,953 shares at $75.56 ($921K) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($921k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.56 | 3,984 | $301K | 32.7% |
| 2 | $75.56 | 3,984 | $301K | 32.7% |
| 3 | $80.00 | 3,985 | $319K | 34.6% |
| Total | $77.04 avg | 11,953 | $921K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |